Lang, G. E. Et Al. 2013. Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study. OPHTHALMOLOGY , vol.120, no.10 , 2004-2012.

Lang, G. E., Berta, A., Eldem, B. M., Simader, C., Sharp, D., Holz, F. G., ... Sutter, F.(2013). Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study. OPHTHALMOLOGY , vol.120, no.10, 2004-2012.

Lang, Gabriele Et Al. "Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study," OPHTHALMOLOGY , vol.120, no.10, 2004-2012, 2013

Lang, Gabriele E. Et Al. "Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study." OPHTHALMOLOGY , vol.120, no.10, pp.2004-2012, 2013

Lang, G. E. Et Al. (2013) . "Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study." OPHTHALMOLOGY , vol.120, no.10, pp.2004-2012.

@article{article, author={Gabriele E. Lang Et Al. }, title={Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study}, journal={OPHTHALMOLOGY}, year=2013, pages={2004-2012} }